Sengenics Buys Oxford Gene Technology's Protein Array Platform | GenomeWeb

NEW YORK (GenomeWeb) – Sengenics today announced it has acquired Oxford Gene Technology's protein array technology for an undisclosed amount. 

The technology, which will be rebranded Immunome, is an auto-antibody profiling platform developed as a joint collaboration between the University o fOxford and the University of Cambridge. It is the only array platform in which every protein is full length, correctly folded, and functionally validated, Sengenics said, adding that Immunome ensures that only correctly folded proteins are presented on the array. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.